bullish

Video: MaxCyte - Edison Open House Interview

451 Views05 Feb 2021 21:39
Issuer-paid
SUMMARY

Vivienne Parry talks to Doug Doerfler, President & CEO MaxCyte is a clinical-stage global cell-based therapies and life sciences company that believes in the power of next-generation cell and gene therapies to revolutionize medical treatment and ultimately save lives. For more healthcare content, visit: https://www.edisongroup.com/our-content/?sector=healthcare

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
  • Loading...
x